Nucleic Acid Vaccines: Veterinary Applications

  • L. A. Babiuk
  • P. J. Lewis
  • S. Drunen Little-Van van den Hurk
  • S. Tikoo
  • X. Liang
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 226)

Abstract

Few would disagree that immunization to prevent infectious diseases has significantly impacted the economics of livestock and poultry production globally. Unfortunately, even with these successes, there is a need to extend the impact of such vaccination programs since economic losses continue to plaque producers and in some instances limit the areas of livestock production or reduce the economic return to producers by limiting the export of genetic stock. To increase animal productivity, infectious diseases have been the primary targets for vaccination, although more recently, ectoparasites are also becoming a target for immunization.

Keywords

Fatigue Influenza Tuberculosis Malaria Peritonitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alger NE, Cabrera EC (1972) Increase of death rate of Anopheles stephensi fed on rabbits immunized with mosquito antigen. J Econ Entomol 65:165–168PubMedGoogle Scholar
  2. Allen JR (1994) Host resistance to ectoparasites. Rev Sci Tech Off Int Epiz 13(4): 1287–1303Google Scholar
  3. Allen JR, Humphreys SJ (1979) Immunization of guinea pigs and cattle against ticks. Nature 280: 491–493PubMedCrossRefGoogle Scholar
  4. Atanasiu P (1962) Production de tumeurs chez le hamster par inoculation d’acide desoxyribonucleique extrait de cultures de tissues infectees par le virus de polyome. Acad Sci 254:4228–4230Google Scholar
  5. Babiuk LA, Sabara MI, Hudson GR (1984) Rotavirus and coronavirus infections in animals. Prog Vet Microbiol: 80–120Google Scholar
  6. Babiuk LA, L’Italien J, van Drunen Littel-van den Hurk S, Zamb T, Lawman MJP, Hughes G, Gifford GA (1987) Protection of cattle from bovine herpesvirus type 1 (BHV-1) infection by immunization with individual viral glycoproteins. Virol 159:57–66CrossRefGoogle Scholar
  7. Babiuk LA, Campos M (1992) Respiratory vaccines for farm animals. In: Peters AR (ed) Vaccines for applications. Butterworth, UK, pp 83–115Google Scholar
  8. Babiuk LA, Lewis PJ, Cox G, van Drunen Littel-van den Hurk S, Baca-Estrada M, Tikoo SK (1995a) DNA immunization with bovine herpesvirus-1 genes. In: Liu M (ed) DNA vaccines: a new era in vaccinology. New York Academy of Sciences, NY, pp 50–56Google Scholar
  9. Babiuk LA, van Drunen Littel-van den Hurk S, Tikoo SK (1995b) Immunology of bovine herpesvirus infections. Vet Microbiol 772:47–63Google Scholar
  10. Babiuk LA, Lewis PJ, Suradhat S, van Drunen Littel-van den Hurk S, Baca-Estrada M, Tikoo SK, Yoo D (1996) Polynucleotide immunization: a novel approach to vaccination. Vaccines 96, Cold Spring Harbor, Cold Spring Harbor, NY, pp 33–38Google Scholar
  11. Campos M, Bielefeldt Ohmann H, Hutchings D, Rapin N, Babiuk LA, Lawman MJP (1989) Role of interferon gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 ~(BHV-l)-infected cells. Cell Immunol 120:259–269PubMedCrossRefGoogle Scholar
  12. Cox GJM, Zamb TJ, Babiuk LA (1993) Bovine herpesvirus 1: Immune responses in mice and cattle injected with plasmid DNA. J Virol 67:5664–5667PubMedGoogle Scholar
  13. Davis HL, Michel ML, Whalen RG (1993) DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Gen 2:1847–1851PubMedCrossRefGoogle Scholar
  14. Donnelly JJ, Friedman A, Martinez D, Montgomery DL, Shiver JW, Motzel SL, Ulmer JB, Liu MA (1995) Preclinical efficacy of a prototype DNA vaccines: Enhanced protection against antigenic drift in influenza virus. Nature Medicine 1 (6):583–587PubMedCrossRefGoogle Scholar
  15. Donnelly JJ, Ulmer JB, Liu MA (1993) Immunization with polynucleotides: a novel approach to vaccination. The Immunologist 2:20–26Google Scholar
  16. East L, Kerlin RL, Altmann K, Watson DL (1993) Adjuvants for new veterinary vaccines. Prog Vaccin 4:1–28CrossRefGoogle Scholar
  17. Eisemann CH, Ginnington KC (1994) The peritrophic membrane: its formation, structure, chemical composition and permeability in relation to vaccination against ectoparasitic arthropods. Int J Parasitol 24:15–26PubMedCrossRefGoogle Scholar
  18. Feigner PL (1995) Cationic lipids for direct in vivo gene delivery. In: Liu M (ed) DNA vaccines: a new era in vaccinology. New York Academy of Sciences, NY, 772:126–139Google Scholar
  19. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JS, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc Natl Acad Sci USA 90:11478–11482PubMedCrossRefGoogle Scholar
  20. Gao Y, Daley MJ, Splitter GA (1995) BHV-1 glycoprotein 1 and recombinant interleukin IB efficiently elicit mucosal IgA response. Vaccine 13:871PubMedCrossRefGoogle Scholar
  21. Haensler J, Szoka (Jr) FC (1993) Polyamidoanine cascade polymers mediate efficient transfection of cells in culture. Biconjug-Chem 4(5):372–379CrossRefGoogle Scholar
  22. Harland RJ, Potter AA, van Drunen Littel-van den Hurk S, Van Donkersgoed J, Parker MD, Zamb TJ, Janzen ED (1992) Ale effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves. Can Vet J 33:734–741PubMedGoogle Scholar
  23. Ho DY (1994) Amplicon-based herpes simplex virus vectors. Methods Cell Biol 43:191–210PubMedCrossRefGoogle Scholar
  24. Hoffmann SL, Sedegah M, Hedstrom RC (1994) Protection against malaria by immunization with a plasmodium yoelei circums parazoite protein nucleic acid vaccine. Vaccine 12:1529–1533CrossRefGoogle Scholar
  25. Hughes HPA, Babiuk LA (1992a) The adjuvant potential of cytokines. Biotech Therap 3:101–117Google Scholar
  26. Hughes HPA, Campos M, Godson DL, van Drunen Littel-van den Hurk S, McDougall L, Rapin N, Zamb T, Babiuk LA (1991) Immunopotentiation of bovine herpesvirus subunit vaccination by interleukin-2. Immunol 74:461–466Google Scholar
  27. Hughes HPA, Campos M, Potter AA, Babiuk LA ~(1992b) Molecular chimerization of Pasteurella haemolytica leukotoxin to interleukin-2: effects on cytokine and antigen function. Infection and Immunity 60:565–570PubMedGoogle Scholar
  28. Inokuma H, Kerlin RL, Kemp DH, Willadsen P (1993) Effects of cattle tick (Boophilus microplus) infestation on the bovine immune system. Vet Parasitol 47:107–118PubMedCrossRefGoogle Scholar
  29. Kerlin RL, East U (1992) Potent immununosuppression by secretory/excretory products of larvae of the sheep blowfly Lucilia cuprina. Parasite Immunol 14:595–604PubMedCrossRefGoogle Scholar
  30. Kit S, Qavi H, Gaines JD, Billinglsey P (1985) Thymidine kinase negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch Virol 86:53–83CrossRefGoogle Scholar
  31. Kit S, Sheppard M, Ichimura H, Kit M (1987) Second generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes. Am J Vet Res 48:780–793PubMedGoogle Scholar
  32. Longley C, Axelrod H, Midha S, Kakarla R, Kogan NA, Sofia M, Babu S, Wierichs L, Walker S (1995) Conjugates of glycosylated steroids and polyamines as novel non-viral gene delivery systems. In: Liu M (ed) DNA vaccines: a new era in vaccinology. New York Academy of Sciences, NY, 772:268–270Google Scholar
  33. Lowrie DB, Tascon RE, Colston MJ, Silva CL (1994) Towards a DNA vaccine against tuberculosis. Vaccine 356:152–154Google Scholar
  34. Michel MIL, Davis HL, Schleef M, Manicin M, Tiollais P, Whalen RG (1995) DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci 92:5307–5311PubMedCrossRefGoogle Scholar
  35. Morein B, Lovgren K, Hoglund S, Sundquist B (1987) The ISCOM. An immunostimulating complex. Immunol Today 8:333–338CrossRefGoogle Scholar
  36. Nick S, Klaws J, Friebel K, Birr C, Hunsmann G, Bayer H (1990) Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from feline leukemia virus glycoprotein sequence. J Gen Virol 71:77–83PubMedCrossRefGoogle Scholar
  37. Nogge G (1978) Aposymbiotic tsetse flies, Glossina morsitans morsitans, obtained by feeding on rabbits immunized specifically with symbionts. J Insect Physiol 24:299–304PubMedCrossRefGoogle Scholar
  38. Olsen CW, Corapi WV, Ngichake CK, Baines JD, Scott FW (1992) Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody dependent enhancement of infection of feline macrophages. J Virol 66:956–965PubMedGoogle Scholar
  39. Opdebeeck JP (1994) Vaccines against blood-sucking arthropods. Vet Parasitol 54:205–222PubMedCrossRefGoogle Scholar
  40. Pastoret PP, Brochier B, Languet B, Thomas I, Paguot A, Bauduin B, Kieny MP, Lecocq JP, DeBruyn J, Costy F, Antonine H (1988) First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus. Vet Rec 123:481–483PubMedCrossRefGoogle Scholar
  41. Pedersen NC, Johnson L, Bird C, Theilen GH (1986) Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated vaccines were protective. Vet Immuno and Immunopathol 11:123–148CrossRefGoogle Scholar
  42. Potter AA, Harland RJ (1990) Development of a recombinant subunit vaccine for Pasteurella haemo- lytica. American Society of Microbiology Biotechnology Conference, June 1990, Chicago, ILGoogle Scholar
  43. Robinson HL, Hunt LA, Webster RG (1993a) Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid. DNA Vaccine 11(9):957–960CrossRefGoogle Scholar
  44. Robinson HL, Hunt LA, Webster RG (1993b) Protection against a lethal influenza challenge by immunization with a hemagglutinin expressing plasmid. DNA Vaccine 11:957–960CrossRefGoogle Scholar
  45. Tang DC, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356:152–154PubMedCrossRefGoogle Scholar
  46. Theodos CM, Titus RG (1993) Salivary gland material from the sandfly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro. Parasite Immunol 15(8):481–487PubMedCrossRefGoogle Scholar
  47. Tikoo SK, Fitzpatrick DR, Babiuk LA, Zamb TJ (1990) Molecular coloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J Virol 64:5132–5142PubMedGoogle Scholar
  48. Tikoo SK, Zamb TJ, Babiuk LA (1993) Analysis of bovine herpesvirus 1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses. J Virol 67:2103–2109PubMedGoogle Scholar
  49. Tikoo SK, Campos M, Babiuk LA (1995) Bovine herpesvirus-1 (BHV-1): Biology pathogenesis and control. Adv Virus Res 45:191–223PubMedCrossRefGoogle Scholar
  50. Ulmer J, Deck RR, DeWitt CM, Friedman A, Donnelly J, Liu M (1994a) Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541–1545PubMedCrossRefGoogle Scholar
  51. Ulmer JB, Deck RR, DeWitt CM, Friedman A, Donnelly JJ, Liu MA (1994b) Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541–1544PubMedCrossRefGoogle Scholar
  52. Ulmer JG, Donnelly JJ, Parker SE, Rhodes GH, Felguer PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding in viral protein. Science 259:1745–1749PubMedCrossRefGoogle Scholar
  53. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Rutter BD (1982) Synthesis and assembly of hepatitis B surface antigen particles in yeast. Nature 298:347–350PubMedCrossRefGoogle Scholar
  54. van Drunen Littel-van den Hurk S, Parker NW, Massie B, van den Hurk JV, Harland R, Babiuk LA, Zamb TJ (1993a) Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11:25–35CrossRefGoogle Scholar
  55. van Drunen Littel-van den Hurk S, Tikoo SK, Liang X, Babiuk LA (1993b) Bovine herpesvirus-1 vaccines. Immunol Cell Biol 71:405–42CrossRefGoogle Scholar
  56. Webster RG, Fynan EF, Santoro JC, Robinson H (1994) Protection of ferret against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12(16): 1495–1498PubMedCrossRefGoogle Scholar
  57. Weiss WR, Berzovsky JA, Houghten R, Sedegah M, Hollingdale M, Hoffman SL (1992) A T cell clone directed at the circumosporozoite protein which protects mice against both P yoelli and P berghei. J Immunol 149:2103–2109PubMedGoogle Scholar
  58. Whitton IL, Sheng N, Oldstone M, McKee T (1993) A “strong of beads” vaccines, comprising linked minigenes, confers protection from lethal virus challenge. J Virol 67:348–352PubMedGoogle Scholar
  59. Wikel SK, Ramachandra RN, Bergman DK (1994) Tick-induced modulation of the host immune response. Int J Parasitol 24:59–66PubMedCrossRefGoogle Scholar
  60. Willadsen P, Eisemann CH, Tellam RL (1993) “Concealed antigens” expanding the range of immunological targets. Parasitol Today 9:132–135PubMedCrossRefGoogle Scholar
  61. Willadsen P, McKenna RV, Riding G A (1988) Isolation from the cattle tick Boophilus microplus of antigenic material capable of eliciting a protective immunological response in the bovine host. Int J Parasitol 18:183–189PubMedCrossRefGoogle Scholar
  62. Williams RS, Johnston SA, Reidy M, Devit MJ, McElligott SC, Sanford JC (1991) Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci USA 88:2726–2730PubMedCrossRefGoogle Scholar
  63. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle cells in vivo. Science 247:1465–1468PubMedCrossRefGoogle Scholar
  64. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertle HC (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132–140PubMedCrossRefGoogle Scholar
  65. Xu D, Liew FY (1994) Genetic vaccination against leishmaniasis. Vaccine 12:1534–1536PubMedCrossRefGoogle Scholar
  66. Yilma T, Hsu D, Jones L, Owens S (1988) Protection of cattle against rinderpest and vaccinia virus recombinants expressing the HA and F genes. Science 242:1058–1061PubMedCrossRefGoogle Scholar
  67. Zijl M, Wensvoort G, de Kluyver E, Hulst M, van den Gulden H, Gielkens A, Bems A, Moorman R (1991) Live attenuated pseudorabies virus expressing envelope glycoprotein El of hog cholera virus protects swine against both pseudorabies and hog cholera. J Virol 65:2761–2765PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • L. A. Babiuk
    • 1
  • P. J. Lewis
    • 1
  • S. Drunen Little-Van van den Hurk
    • 1
  • S. Tikoo
    • 1
  • X. Liang
    • 1
  1. 1.Veterinary Infectious Disease OrganizationSaskatoonCanada

Personalised recommendations